Literature DB >> 3383114

Low-grade soft tissue sarcomas of the extremities. Analysis of risk factors for metastasis.

J H Donohue1, C Collin, C Friedrich, J Godbold, S I Hajdu, M F Brennan.   

Abstract

Of 130 patients with low-grade localized soft tissue sarcomas of the extremities treated at Memorial Hospital between 1968 and 1978, 18 (14%) developed metastases. The risk of metastasis could not be predicted by the clinical or pathologic size, tumor depth, proximal location, recurrence before presentation or subsequent to treatment at our institution, the type of surgical and adjuvant therapies, and the adequacy of surgical margins. The median age of patients with metastases was 10 years older than the other patients (57.5 years and 47.5 years, respectively). Of the more common sarcomas in this study, malignant peripheral nerve tumors and malignant fibrous histiocytomas had the highest prevalence of metastasis (27% (three of 11) and 17% (three of 18), respectively). Although patients with low-grade extremity sarcomas treated during the first 5 years of this review had an increased rate of metastasis, no other patient, tumor, or treatment variable examined significantly differed between the two time periods. Although grade alone is a good predictor of the risk of metastasis from soft tissue sarcomas of the extremity, 14% of patients in this series with low-grade histology developed metastases. Further review of larger numbers of these tumors should be undertaken in an effort to more definitively identify risk factors predictive of metastatic potential in low-grade sarcomas.

Entities:  

Mesh:

Year:  1988        PMID: 3383114     DOI: 10.1002/1097-0142(19880701)62:1<184::aid-cncr2820620128>3.0.co;2-c

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  8 in total

1.  Multifactorial analysis of survival in primary extremity liposarcoma.

Authors:  H R Chang; J Gaynor; C Tan; S I Hajdu; M F Brennan
Journal:  World J Surg       Date:  1990 Sep-Oct       Impact factor: 3.352

2.  Image analysis derived ploidy and proliferation indices in soft tissue sarcomas: comparison with clinical outcome.

Authors:  B A Michie; C Black; R P Reid; A Barrett; D L Hamblen
Journal:  J Clin Pathol       Date:  1994-05       Impact factor: 3.411

3.  A retrospective statistical analysis of high-grade soft tissue sarcomas.

Authors:  Gregory G Kolovich; Adam N Wooldridge; Jonathan M Christy; Martha K Crist; Joel L Mayerson; Thomas J Scharschmidt
Journal:  Med Oncol       Date:  2011-05-07       Impact factor: 3.064

4.  Comparison of charges related to radiotherapy for soft-tissue sarcomas treated by preoperative external-beam irradiation versus interstitial implantation.

Authors:  N A Janjan; A W Yasko; G P Reece; M J Miller; J A Murray; M I Ross; M M Romsdahl; M J Oswald; T G Ochran; R E Pollock
Journal:  Ann Surg Oncol       Date:  1994-09       Impact factor: 5.344

5.  Does malignant transformation of benign soft-tissue tumours occur? A clinicomorphological study of ten initially misdiagnosed soft-tissue sarcomas.

Authors:  C Zornig; S Schröder
Journal:  J Cancer Res Clin Oncol       Date:  1992       Impact factor: 4.553

6.  Why do patients with low-grade soft tissue sarcoma die?

Authors:  Robert J Canter; Li-Xuan Qin; Cristina R Ferrone; Robert G Maki; Samuel Singer; Murray F Brennan
Journal:  Ann Surg Oncol       Date:  2008-10-01       Impact factor: 5.344

7.  The role of multimodality therapy in soft-tissue sarcoma.

Authors:  M F Brennan; E S Casper; L B Harrison; M H Shiu; J Gaynor; S I Hajdu
Journal:  Ann Surg       Date:  1991-09       Impact factor: 12.969

8.  Resection of brain metastases from sarcoma.

Authors:  M Wroński; E Arbit; M Burt; G Perino; J H Galicich; M F Brennan
Journal:  Ann Surg Oncol       Date:  1995-09       Impact factor: 5.344

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.